BB Biotech’s Onyx Pharmaceuticals ONXX Stock Holding History
Bought
Maintained
Sold
BB Biotech's ONXX Position: Q4 2013 in Review
BB Biotech sold out of Onyx Pharmaceuticals (ONXX) in Q4 2013, closing a stake of 339,870 shares — an estimated $42.4M sold.
BB Biotech first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $47.4M in Q2 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.
- BB Biotech reported no remaining Onyx Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
- BB Biotech sold 339,870 Onyx Pharmaceuticals shares in Q4 2013, an estimated $42.4M.
- BB Biotech first reported a position in Onyx Pharmaceuticals in Q2 2013 and held it in 2 quarters.
- BB Biotech's Onyx Pharmaceuticals position peaked at $47.4M in Q2 2013.
- 0 funds tracked by Wall St. Rank held Onyx Pharmaceuticals as of Q4 2013.
Based on BB Biotech's 13F filing for Q4 2013, filed 12 Feb 2014.